Navigation Links
American Red Cross Defends Use of Emblem and Mission

Johnson & Johnson's complaint against humanitarian organization distorts

history and law

WASHINGTON, Aug. 10 /PRNewswire-USNewswire/ -- In response to the August 8 lawsuit filed against it by Johnson & Johnson (J&J), the American Red Cross today released a detailed rebuttal, providing the legal and historical framework for its use of the red cross emblem.

"The mission of the Red Cross is to prevent, prepare for and respond to disasters and emergencies, and people look to the Red Cross emblem and see a worldwide symbol of humanitarianism," said Mark W. Everson, President and CEO of the American Red Cross. "The Red Cross will vigorously defend and protect our emblem and mission."

The Red Cross has been selling first aid kits commercially in the United States since 1903. Until now, J&J has never challenged this activity. In fact, for over 100 years, J&J and the Red Cross have enjoyed their concurrent right to use the Red Cross emblem.

By offering Red Cross first aid, health, safety and emergency preparedness products at retail locations, the Red Cross is reaching more families and making it easier for Americans to get prepared. The money the Red Cross receives in the sale of these products to consumers is reinvested in its humanitarian programs and services.

The Red Cross, a nonprofit, received only $2 million in revenue from the sale of its products in 2006. J&J, a corporation, received $53.3 billion in annual revenue in 2006.

"We hope that Johnson & Johnson will act as a good corporate citizen and recognize the right of the American Red Cross to use our own emblem to carry out our mission -- not stand in the way," Everson said.

"Our legal argument is based on solid substantiated facts," he continued. "J&J has taken a criminal statute intended by Congress to protect the American Red Cross and is now using it to distort history and the law."


Red Cross Established First Use of Emblem:

1. The Red Cross began using the red cross emblem in 1881, six years

before Johnson & Johnson (J&J) began using the emblem in 1887.

2. J&J obtained a trademark registration in 1887, but did not object to

the Red Cross use of the emblem at that time.

3. The Red Cross was first chartered by Congress in 1900, and that

charter was amended in 1905. The 1905 amendment gave the Red Cross the

use of the emblem, and specifically stated that "in carrying out its

purposes under this [charter], [the Red Cross] may have the use, as an

emblem and badge, a Greek red cross on a white ground..." The Charter

grants the Red Cross "to conduct other activities consistent with" its

Charter purposes.

4. In the 1905 Charter amendment, Congress intended the Red Cross to have

the exclusive use of the emblem, and this was confirmed by the U.S. Patent

and Trademark Office (PTO) when they specifically reserved an application

serial number for the Red Cross to register its Emblem in EVERY class of

goods and services without limitation.

5. J&J was concerned that it would lose its right to use the emblem on

its products, so it lobbied Congress to allow it to continue, or

"grandfather" its use of the red cross symbol. Congress passed a law

making it a crime for third parties other than the Red Cross to use a red

cross symbol fraudulently but also permitted J&J and the dozens of other

companies to continue to use the red cross emblem for only those products

used by those companies as of that time. Congress made this a criminal

statute specifically to protect the Red Cross from unauthorized users of

the emblem.

"Barton Agreement" Never Ratified

6. In 1895, when Congress was first considering legislation to charter

the Red Cross, J&J went to Clara Barton and negotiated an agreement (the

"Barton Agreement") that would have permitted J&J to continue to use the

red cross emblem if Congress gave the use of the emblem to the Red Cross

in a charter.

7. The Barton Agreement was effective only if Congress passed a specific

law that would have prohibited J&J from continuing to use a red cross

symbol. Congress did not pass the law, so the agreement never took


8. Thus, the Barton Agreement was effectively rendered null and void.

J&J admitted this fact in testimony before Congress in 1942 in hearings in

the House of Representatives on the "Protection of the Name and Emblem of

the Red Cross." 77th Cong., 2d Sess. 279-81 (1942).

9. It is noteworthy that although J&J makes reference to the Barton

Agreement in its lawsuit against the Red Cross, J&J did not quote the

limiting language in the complaint, nor did it include a copy of the

Barton Agreement with its other exhibits attached to the complaint. In

fact, there is no claim of ANY breach of the Barton Agreement by the Red

Cross in the lawsuit.

Dispute Over Emblem Based on Profit

10. The Red Cross has been selling first aid kits commercially in the

United States since 1903. Until now, J&J has never challenged this

activity. Thus, for over 100 years, J&J and the Red Cross enjoyed their

concurrent right to use the red cross emblem in commerce.

11. In fact, over the past century, J&J and the Red Cross have joined in

lawsuits against infringers of the right of the Red Cross and J&J to use

the red cross emblem.

12. In 2003, J&J began to complain to the Red Cross about licensing third

parties to sell Red Cross first aid kits in retail stores. Red Cross

tried to partner with J&J on preparedness and on this issue, but these

conversations never led to an agreement.

13. J&J then began telling retail stores that carried Red Cross products

that there was "an existing trademark dispute" between J&J and the Red


14. During the past several years, on several occasions, J&J has tried to

convince the Red Cross to limit its use of the red cross emblem on

licensed products in retail stores. Only within the past three weeks has

it become apparent to the Red Cross that J&J was possibly doing more than

saber-rattling. Since that time, the Red Cross has been working

carefully, analyzing its legal position and weighing options.

Red Cross Disputes J&J's Claims in Lawsuit

15. J&J's first claim is for "Contractual and Equitable Estoppel." This

claim does not mention any breach of any contract, and does not mention at

all the Barton Agreement. It merely claims that the Red Cross made

certain historical statements that it "would not enter into such

commercial licenses" regarding the sale of certain Red Cross products that

J&J relied upon to its detriment.

16. J&J's second claim is for "Violation of 18 U.S.C. Section 706." J&J

alleges that the Red Cross and its licensing partners are somehow

violating this statute. What J&J's lawsuit fails to recognize is that this

criminal statute originally was passed by Congress as a shield to protect

the Red Cross from other companies that fraudulently infringe upon the

right of ARC to use the red cross emblem. At no time has any federal

agency, including the Department of Justice, ever claimed that the Red

Cross was in violation of the use of its red cross emblem that Congress

gave to it more than 102 years ago. Now J&J is attempting to use this

criminal statute as a sword against the Red Cross.

17. J&J's third and final claim is for a claim that does not even involve

the Red Cross. It is for a separate issue against one of the Red Cross's


18. In its claims for relief, J&J asks the court to order the Red Cross

from undertaking any "sale to the consuming public" of emergency

preparedness and related products, even on the Internet and through Red

Cross chapters and outlets. More amazing is the request that the court

order the Red Cross to surrender to J&J all of these preparedness products

"for destruction" by J&J.

19. To date, the Red Cross has generated about $2 million in funds for

the organization from the sale of these products in retail stores. In

contrast, J&J recently made $11 billion in profits in one year. This

lawsuit is not about any threat to J&J's retail business.

20. In short, this lawsuit is a direct attack on the American Red Cross

and its right to use the red cross emblem -- a right that was given by

Congress. Both the Red Cross and J&J have the legal right to use the

emblem as they deem necessary to fulfill their respective missions, for

the Red Cross to prepare the public for emergencies and disasters, and for

J&J to make money in the marketplace. There is no merit to any of the

legal claims asserted by J&J in this lawsuit. The Red Cross intends to

vigorously defend the suit. We will not let J&J take the Red Cross out of

the name American Red Cross.

The American Red Cross helps people prevent, prepare for and respond to emergencies. Last year, almost a million volunteers and 35,000 employees helped victims of almost 75,000 disasters; taught lifesaving skills to millions; and helped U.S. service members separated from their families stay connected. Almost 4 million people gave blood through the Red Cross, the largest supplier of blood and blood products in the United States. The American Red Cross is part of the International Red Cross and Red Crescent Movement. An average of 91 cents of every dollar the Red Cross spends is invested in humanitarian services and programs. The Red Cross is not a government agency; it relies on donations of time, money, and blood to do its work.

SOURCE American Red Cross
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can be time ... preset onto their media," said Christina Austin - CEO of Pixel Film Studios. ... and easily add stylish color grades to their footage. A LUT is a Lookup ...
(Date:5/28/2016)... ... ... of the city where’s it’s easy to spot the neon lights of chains serving fast ... diners with a taste for real food. , On May 13, the Best ... urban casual restaurant focusing on dishes made by hand with wholesome, organic ingredients that are ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon ... to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel ... year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke ... a sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics ... individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance from ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... educate the many who are unaware of the plight of aphasia. In collaboration ... within the “Stroke Awareness” campaign. , The link between stroke and aphasia is ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 Hutchison China ... focused on the highly lucrative global oncology and ... of potential first-in-class or best-in-class tyrosine kinase inhibitor ... with strategic partners. HCM,s profitable Chinese healthcare business ... We expect progress of the mid-to-late-stage pipeline during ...
(Date:5/26/2016)... , May 26, 2016 A ... growth is the emergence of new treatments. Cardax, a ... for osteoarthritis treatment. The therapy is expected to fulfil ... Research UK is conducting studies to develop new treatments ... where the genes involved in osteoarthritis are being investigated, ...
(Date:5/25/2016)... 25, 2016 According to a ... (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), ... (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", ... Animation Market for the forecast period of 2016 to ... Million by 2021 from USD 117.3 Million in 2016, ...
Breaking Medicine Technology: